Introduction .
However ,  many drawbacks still exist regarding themethod of RT delivery as well as the toxicity of combinationadjuvant chemotherapy .
Purpose .
The primary endpoint is overall survival ,  secondaryendpoints are disease-free survival ,  rate of loco-regionalrecurrence ,  and treatment-related toxicity/morbidity .
No prior or concurrent chemo- ,  immuno- ,  radio- ,  and endocrine therapy are allowed .
Statistical and ethical considerations .
